 |
Prospector
Profile
07.1430
|
| |
| Universal Detection Technology Corp. |
NAICS |
334519 |
| 9595 Wilshire Boulevard, Suite 700
Beverly Hills, CA 90212 |
Description |
Detectors Mfg. |
| (310) 248-3655 |
Employees |
5 |
| http://www.udetection.com/ |
Revenue |
(mil) |
0.1110 |
| |
Income |
(mil) |
-2.7020 |
| |
Assets |
(mil) |
0.3280 |
| |
Liability |
(mil) |
3.4820 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Universal Detection Technology Corp. had a net loss of $641,883 for the three months ended June 30, 2007, lower than the $675,371 net loss incurred during the second quarter of 2006. The Company's balance sheet at June 30, 2007 showed an accumulated deficit of $35,061,432 and stockholders' deficit of $3,212,021. It also has strained liquidity with $18,525 in total current assets available to pay $3,418,617 in total current liabilities.
|
| |
|
Intellectual Property:
On September 30, 2003, the Company entered into a license agreement with Caltech whereby it received licenses to produce, provide and sell proprietary products, processes and services for use in the detection of pathogens, spores, and biological warfare agents. These licenses include a worldwide exclusive license to the patent rights referenced in the Technology Affiliates Agreement with NASA's Jet Propulsion Laboratory (JPL) and a worldwide nonexclusive license to rights in related proprietary technology. The United States government also has a worldwide, non-exclusive, non-transferable license to use any inventions covered by the patent rights or the rights in the proprietary technology. As part of the sale of wholly-owned subsidiary Dasibi Environmental Corp. to a third party in March 2002, the Company obtained a perpetual nonexclusive license to exploit all of Dasibi's intellectual property rights outside of mainland China. [SEC Filing 10-KSB 04-16-07]
|
| |
|
Description:
The Company engages in the research and development of bioterrorism detection devices in the United States.
|
| |
|
Officers:
Jacques Tizabi (Pres., CEO, CFO & Dir.); Michael Collins (Sec. & Dir.); Ali Moussavi(VP); Matin Emouna (Dir.)
|
| |
|
Auditor:
A.J. Robbins PC
|
| |
|
Securities:
Common Stock-Symbol UDTT.OB; OTC BB;
465,840,278 common shares outstanding as of August 9, 2007.
|
| |
| |
| |
| return to main page |
|
|
